Topical Scar Treatment Market Size, Share & Trends Analysis Report By Product (Creams, Gels, Silicone), By Scar Type (Atrophic Scars, Hypertrophic & Keloid Scars), By Distribution Channel (Retail Pharmacies, Online), By Region, And Segment Forecasts, 2025 - 2030
Polydextrose Market Growth & Trends
The global polydextrose market size is expected to reach USD 498.0 million by 2030, registering a CAGR of 5.8% from 2025 to 2030, according to a new report by Grand View Research, Inc.Rising demand to enhance the non-dietary fiber content in food is expected to boost the market growth. Increasing utilization of polydextrose as sugar supplement in food and as a prebiotic dietary fiber is projected to propel the market demand.
Major raw materials used for the production of polydextrose include maltitol, sorbitol, glucose, starch, vegetable oil & fat, soy flour, citric acid, and maltodextrins. Growing demand for beverages & nutritional foods, owing to various health benefits is anticipated to drive the demand for polydextrose market over the forecast period.
Increasing demand for polydextrose as functional food additive owing to reduce blood sugar and blood fat is expected to spur the market over the forecast period. Favorable properties such as low sugar content and low glycemic index are used to produce diabetic and medical foods. Polydextrose functionality includes weight management, fat reduction, prebiotic, and satiety. The products maintain the body functions properly, owing to its rich fiber and low calorie content.
Regulatory authorities include Food & Drug Administration (FDA),Food Safety and Standards Authority of India (FSSAI), and Health Canada (HC). The companies are investing in R&D activities in order to enhance their product offerings to meet the growing industry demand. Key players in the market include Tate & Lyle, Danisco A/S, and Cargill Inc among others
Polydextrose Market Report Highlights
- The powder segment accounted for a leading revenue share of 72.8% in the global market in 2024 on account of the growing use of this form in bakery & confectionery items and functional foods.
- The beverages segment accounted for a leading revenue share in the global market in 2024. Increasing consumption of nutritional and functional beverages globally has provided a major growth avenue to companies involved in manufacturing polydextrose.
- North America polydextrose market accounted for a leading revenue share of 34.7% in the global industry in 2024.
- The Asia Pacific region is anticipated to expand at the fastest CAGR from 2025 to 2030. The rapidly growing population in regional economies such as China, Japan, and India, coupled with the increasing incidence of various lifestyle diseases, has highlighted the need for functional ingredients such as polydextrose in food items.
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Scar Type
- 1.2.3. Distribution Channel
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Scar type outlook
- 2.2.3. Distribution channel outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Topical Scar Treatment Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Growing demand for aesthetics
- 3.2.1.2. Growing number of road accidents and burn cases
- 3.2.1.3. Growing technological advancements
- 3.2.2. Market restraint analysis
- 3.2.2.1. Limited effectiveness for severe scars
- 3.2.2.2. Consumer skepticism and slow adoption
- 3.2.3. Market restraint analysis
- 3.2.3.1. Growing awareness of skincare and personal appearance
- 3.2.3.2. Growing popularity of e-commerce
- 3.3. Topical Scar Treatment Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s Five Forces
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Environmental landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Legal landscape
- Chapter 4. Global Topical Scar Treatment Market: Product Estimates & Trend Analysis
- 4.1. Topical Scar Treatment Market: Product Dashboard
- 4.2. Topical Scar Treatment Market: Product Movement Analysis
- 4.3. Topical Scar Treatment Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 4.4. Creams
- 4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.5. Gels
- 4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.6. Silicon Sheets
- 4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.7. Others
- 4.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- Chapter 5. Global Topical Scar Treatment Market: Scar Type Estimates & Trend Analysis
- 5.1. Topical Scar Treatment Market: Scar Type Dashboard
- 5.2. Topical Scar Treatment Market: Scar Type Movement Analysis
- 5.3. Topical Scar Treatment Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 5.4. Atrophic Scars
- 5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.5. Hypertrophic and Keloid Scars
- 5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.6. Contracture Scars
- 5.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.7. Stretch Marks
- 5.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- Chapter 6. Global Topical Scar Treatment Market: Distribution Channel Estimates & Trend Analysis
- 6.1. Topical Scar Treatment Market: Distribution Channel Dashboard
- 6.2. Topical Scar Treatment Market: Distribution Channel Movement Analysis
- 6.3. Topical Scar Treatment Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 6.4. Hospital Pharmacies
- 6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.5. Retail Pharmacies
- 6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.6. Online
- 6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.7. Hypermarkets/ Supermarkets
- 6.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- Chapter 7. Regional Estimates & Trend Analysis by Product, Scar Type, Distribution Channel
- 7.1. Global Topical Scar Treatment Market: Regional Dashboard
- 7.2. Global Topical Scar Treatment Market: Regional Movement Analysis
- 7.3. Global Topical Scar Treatment Market Size & Forecasts and Trend Analyses by Product, Scar Type, Distribution Channel, 2018 to 2030
- 7.4. North America
- 7.4.1. U.S.
- 7.4.1.1. Key country dynamics
- 7.4.1.2. Regulatory framework/ reimbursement structure
- 7.4.1.3. Competitive scenario
- 7.4.1.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.2. Canada
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Regulatory framework/ reimbursement structure
- 7.4.2.3. Competitive scenario
- 7.4.2.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Mexico
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Regulatory framework/ reimbursement structure
- 7.4.3.3. Competitive scenario
- 7.4.3.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5. Europe
- 7.5.1. Germany
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Regulatory framework/ reimbursement structure
- 7.5.1.3. Competitive scenario
- 7.5.1.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.2. UK
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework/ reimbursement structure
- 7.5.2.3. Competitive scenario
- 7.5.2.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Spain
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework/ reimbursement structure
- 7.5.3.3. Competitive scenario
- 7.5.3.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.4. France
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework/ reimbursement structure
- 7.5.4.3. Competitive scenario
- 7.5.4.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Italy
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Regulatory framework/ reimbursement structure
- 7.5.5.3. Competitive scenario
- 7.5.5.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Denmark
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Regulatory framework/ reimbursement structure
- 7.5.6.3. Competitive scenario
- 7.5.6.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.7. Sweden
- 7.5.7.1. Key country dynamics
- 7.5.7.2. Regulatory framework/ reimbursement structure
- 7.5.7.3. Competitive scenario
- 7.5.7.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.8. Norway
- 7.5.8.1. Key country dynamics
- 7.5.8.2. Regulatory framework/ reimbursement structure
- 7.5.8.3. Competitive scenario
- 7.5.8.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. China
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Regulatory framework/ reimbursement structure
- 7.6.1.3. Competitive scenario
- 7.6.1.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.2. India
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework/ reimbursement structure
- 7.6.2.3. Competitive scenario
- 7.6.2.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Japan
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Regulatory framework/ reimbursement structure
- 7.6.3.3. Competitive scenario
- 7.6.3.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.4. South Korea
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Regulatory framework/ reimbursement structure
- 7.6.4.3. Competitive scenario
- 7.6.4.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Australia
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Regulatory framework/ reimbursement structure
- 7.6.5.3. Competitive scenario
- 7.6.5.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.6. Thailand
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Regulatory framework/ reimbursement structure
- 7.6.6.3. Competitive scenario
- 7.6.6.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7. Latin America
- 7.7.1. Brazil
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Regulatory framework/ reimbursement structure
- 7.7.1.3. Competitive scenario
- 7.7.1.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7.2. Argentina
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework/ reimbursement structure
- 7.7.2.3. Competitive scenario
- 7.7.2.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8. MEA
- 7.8.1. South Africa
- 7.8.1.1. Key country dynamics
- 7.8.1.2. Regulatory framework/ reimbursement structure
- 7.8.1.3. Competitive scenario
- 7.8.1.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8.2. Saudi Arabia
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Regulatory framework/ reimbursement structure
- 7.8.2.3. Competitive scenario
- 7.8.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8.3. UAE
- 7.8.3.1. Key country dynamics
- 7.8.3.2. Regulatory framework/ reimbursement structure
- 7.8.3.3. Competitive scenario
- 7.8.3.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8.4. Kuwait
- 7.8.4.1. Key country dynamics
- 7.8.4.2. Regulatory framework/ reimbursement structure
- 7.8.4.3. Competitive scenario
- 7.8.4.4. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2024
- 8.3.4. Smith & Nephew
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Merz North America, Inc.
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. LUMENIS
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Enaltus LLC
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Sonoma Pharmaceuticals, Inc.
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Mölnlycke Health Care
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Cynosure, Inc.
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. CCA Industries, Inc.
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Product benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. Scar Heal Inc.
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Product benchmarking
- 8.3.12.4. Strategic initiatives
- 8.3.13. NewMedical Technology
- 8.3.13.1. Company overview
- 8.3.13.2. Financial performance
- 8.3.13.3. Product benchmarking
- 8.3.13.4. Strategic initiatives
- 8.3.14. Suneva Medical Inc.
- 8.3.14.1. Company overview
- 8.3.14.2. Financial performance
- 8.3.14.3. Product benchmarking
- 8.3.14.4. Strategic initiatives
- 8.3.15. Pacific World Corporation
- 8.3.15.1. Company overview
- 8.3.15.2. Financial performance
- 8.3.15.3. Product benchmarking
- 8.3.15.4. Strategic initiatives
- 8.3.16. Perrigo Company plc
- 8.3.16.1. Company overview
- 8.3.16.2. Financial performance
- 8.3.16.3. Product benchmarking
- 8.3.16.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook